SEC Form 4 · accession 0000899243-19-001073
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Jan 7, 2019
Accepted (ET)
Jan 11, 2019 · 8:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2019 | S | 2,770 | $44.1146 | D | 76,967 | D | |
| Common Stock | holding | — | — | — | 88,473 | I | By Reporting Person's Trust 2 | |
| Common Stock | holding | — | — | — | 500,000 | I | By Reporting Person's Trust 3 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 1 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 2 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 3 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to cover withholding taxes in connection with vesting of Restricted Stock Units reported on Form 4 filed by the Reporting Person on January 3, 2019.